CRON

Cronos Group Inc. (NASDAQ:CRON) is a Canadian cannabinoid company founded in 2012 and headquartered in Toronto. The company went public on the NASDAQ in February 2018, positioning itself as one of the early leaders in the legal cannabis industry. Cronos operates across multiple international markets including Canada, Israel, Germany, the United Kingdom, and Australia, focusing on the cultivation, manufacturing, and distribution of cannabis and hemp-derived products for both medical and adult-use markets. The company has evolved from its early cannabis cultivation roots into a diversified cannabinoid company with a portfolio of consumer brands and a strong focus on product innovation and international expansion.